| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FBXW7_0000500 | Exon-Exon | chr4:153244302-153245335 | chr4:152323150-152324183 | None nt | - |
| hsa_FBXW7_0001300 | Exon-Exon | chr4:153249360-153259088 | chr4:152328208-152337936 | 692 nt | 0.4176 |
| hsa_FBXW7_0001400 | Exon-Exon | chr4:153249360-153268223 | chr4:152328208-152347071 | 834 nt | 0.4341 |
| hsa_FBXW7_0001700 | Exon-Exon | chr4:153250824-153259088 | chr4:152329672-152337936 | 510 nt | 0.4176 |
| hsa_FBXW7_0001800 | Exon-Exon | chr4:153250824-153271276 | chr4:152329672-152350124 | 735 nt | 0.4340 |
| hsa_FBXW7_0002100 | Exon-Exon | chr4:153250824-153333681 | chr4:152329672-152412529 | 1962 nt | 0.3863 |
| hsa_FBXW7_0002200 | Exon-Exon | chr4:153251884-153259088 | chr4:152330732-152337936 | 396 nt | 0.4217 |
| hsa_FBXW7_0002800 | Exon-Exon | chr4:153253748-153259088 | chr4:152332596-152337936 | 259 nt | 0.4324 |
| hsa_FBXW7_0003900 | Exon-Exon | chr4:153268082-153271276 | chr4:152346930-152350124 | 225 nt | 0.4711 |
| hsa_chr4_0190500 | Intergenic-Intergenic | chr4:153272457-153272582 | chr4:152351305-152351430 | 126 nt | 0.3968 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].